Novel therapeutics for the treatment of metastatic melanoma. - Wikidata - wikimedia - TriplyDB

Novel therapeutics for the treatment of metastatic melanoma.

Novel therapeutics for the treatment of metastatic melanoma.

http://www.wikidata.org/entity/Q37486788

about

Circulating serologic and molecular biomarkers in malignant melanoma Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation.The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma.The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells Identification of genetic disparity between primary and metastatic melanoma in human patients.Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy.

P2860

Q27020946-17FFD783-8CA6-4347-8E9D-69D7AE9AFA7A Q33599603-3E0E2C4D-F858-4557-A8D8-7E33F23E0321 Q34020065-3DA14A9D-65C5-407F-9E1F-21DE53E29480 Q35221682-0CC58357-733F-4D5A-A984-50A45AA36E76 Q35228388-2C114BD1-58C3-4D32-BB94-FECE57F00A09 Q36260662-94485EB5-A29A-4729-A009-9834E2B1F30D Q36887861-7CD72BCA-D07B-4C0F-93C5-E2B5961B62C3 Q37731451-CF84BEAF-646A-4744-B2E0-F0D495D36940 Q39541129-01442DA3-D3C1-408A-A04B-3034B0958B75 Q41674312-7A6F8668-152E-4F48-AE58-CF0DAB7A3FD7

P2860

Novel therapeutics for the treatment of metastatic melanoma.

http://www.wikidata.org/entity/Q37486788

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel therapeutics for the treatment of metastatic melanoma.

@en

Novel therapeutics for the treatment of metastatic melanoma.

@nl

type

label

Novel therapeutics for the treatment of metastatic melanoma.

@en

Novel therapeutics for the treatment of metastatic melanoma.

@nl

prefLabel

Novel therapeutics for the treatment of metastatic melanoma.

@en

Novel therapeutics for the treatment of metastatic melanoma.

@nl

P1433

Q37486788-21264340-9CA6-4078-9429-4A221633B5BE

P1476

Q37486788-23542952-02B3-4671-B8C7-0D48A747F45B

P2093

Q37486788-90FD5BF7-4787-4630-A463-CC1F41205235

Q37486788-B2F47559-1CEB-47AD-A18A-C24C21326B20

P2860

Q37486788-0AFEF846-C822-4DFE-8BFD-931734142886

Q37486788-0CF4CFD5-3EA6-4B2E-BA94-70307129742A

Q37486788-0E7AB003-510E-4745-A0D7-89F52F48DECC

Q37486788-11429970-EC60-46C7-8D67-5AFFF0ADFD3D

Q37486788-114F8B2A-94EB-43F0-AC07-CEE51E1DFEB0

Q37486788-122D1C77-CD93-48A3-B293-6A0134AACC0E

Q37486788-13D93BE8-7026-4C1B-9B56-FE66560D7373

Q37486788-150EA817-02BF-49B6-90ED-E1D74E54872B

Q37486788-15873894-707B-4B91-ABBB-16901128A2AF

Q37486788-17EB9F17-86CC-40B6-9022-7CF26B3281C0

P304

Q37486788-0531D5FE-F0F7-4FE0-8BE4-F0B4FC8FA697

P31

Q37486788-CA0DF069-9C3A-490A-A9C3-8E969068F91B

P356

Q37486788-4804DDBB-729A-4FC6-BF02-F6A1DFD2614E

P407

Q37486788-8FFF06E8-CC28-46AE-AC08-521F38F1FC62

P433

Q37486788-1444647C-9B0C-4655-87DA-E817850FE3C1

P478

Q37486788-74F89AF5-C4F2-4F33-96B3-C7875560279F

P577

Q37486788-08290CBC-00AC-43D6-9A97-9027924DE413

P698

Q37486788-089B241E-C129-4961-BBEC-7EDC8255A2E7

P356

P1433

Future Oncology

P1476

Novel therapeutics for the treatment of metastatic melanoma.

@en

P2093

Aaron S Mansfield

http://www.w3.org/2001/XMLSchema#string

Svetomir N Markovic

http://www.w3.org/2001/XMLSchema#string

P2860

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

Adoptive immunotherapy for cancer: building on success

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Cancer immunotherapy: moving beyond current vaccines

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression in patients after transfer of genetically engineered lymphocytes

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Major response to imatinib mesylate in KIT-mutated melanoma.

P304

543-557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.09.15

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19450181

http://www.w3.org/2001/XMLSchema#string